A detailed history of Keybank National Association transactions in Bio Techne Corp stock. As of the latest transaction made, Keybank National Association holds 4,681 shares of TECH stock, worth $361,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,681
Previous 4,066 15.13%
Holding current value
$361,888
Previous $313,000 5.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $40,577 - $47,410
615 Added 15.13%
4,681 $329,000
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $2,905 - $4,302
55 Added 1.37%
4,066 $313,000
Q3 2023

Nov 08, 2023

SELL
$67.52 - $89.42 $4,861 - $6,438
-72 Reduced 1.76%
4,011 $273,000
Q2 2023

Aug 01, 2023

BUY
$73.76 - $85.98 $1,548 - $1,805
21 Added 0.52%
4,083 $333,000
Q1 2023

May 10, 2023

SELL
$71.62 - $86.62 $1,002 - $1,212
-14 Reduced 0.34%
4,062 $301,000
Q4 2022

Jan 31, 2023

BUY
$80.67 - $352.29 $249,108 - $1.09 Million
3,088 Added 312.55%
4,076 $337,000
Q3 2022

Oct 27, 2022

BUY
$282.54 - $391.85 $5,933 - $8,228
21 Added 2.17%
988 $281,000
Q2 2022

Aug 08, 2022

SELL
$322.67 - $449.65 $23,232 - $32,374
-72 Reduced 6.93%
967 $335,000
Q1 2022

Apr 28, 2022

SELL
$353.85 - $487.79 $79,616 - $109,752
-225 Reduced 17.8%
1,039 $450,000
Q4 2021

Feb 07, 2022

SELL
$456.15 - $525.06 $46,983 - $54,081
-103 Reduced 7.53%
1,264 $654,000
Q3 2021

Nov 08, 2021

BUY
$444.87 - $538.88 $27,137 - $32,871
61 Added 4.67%
1,367 $662,000
Q2 2021

Aug 12, 2021

BUY
$387.35 - $450.26 $99,161 - $115,266
256 Added 24.38%
1,306 $588,000
Q1 2021

May 07, 2021

SELL
$314.62 - $411.0 $33,035 - $43,155
-105 Reduced 9.09%
1,050 $401,000
Q3 2019

Nov 04, 2019

BUY
$183.56 - $216.72 $212,011 - $250,311
1,155 New
1,155 $226,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.03B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.